Related Experiment Videos
[Congestive heart failure and paraoxonase].
1Department of Geriatrics, Second Xiangya Hospital, Central South University, Changsha 410011, China.
Hunan Yi Ke Da Xue Xue Bao = Hunan Yike Daxue Xuebao = Bulletin of Hunan Medical University
|February 11, 2003
Summary
Serum paraoxonase (PON) activity significantly decreases in patients with heart failure. Treatment largely elevated PON activity, suggesting its potential role in heart failure management.
Area of Science:
- Biochemistry
- Cardiology
- Biomarkers
Context:
- Heart failure is a complex clinical syndrome.
- Paraoxonase (PON) is an enzyme with antioxidant and anti-inflammatory properties.
- Altered PON activity may contribute to cardiovascular disease pathogenesis.
Purpose:
- To investigate the changes in serum paraoxonase (PON) activity in patients diagnosed with heart failure.
- To compare PON activity between heart failure patients and a healthy control group.
- To explore the relationship between PON activity and inflammatory markers in heart failure.
Summary:
- Serum PON activity was significantly lower in patients with heart failure compared to controls.
- Following treatment, a substantial increase in PON activity was observed in heart failure patients.
- A negative correlation was found between PON activity and tumor necrosis factor-alpha levels in heart failure patients.
Impact:
- This study highlights a significant reduction in PON activity in heart failure patients.
- The findings suggest that PON activity could serve as a potential biomarker for heart failure.
- Restoration of PON activity may offer a therapeutic avenue for managing heart failure.